标题
Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 6, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-11-05
DOI
10.3389/fendo.2015.00168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
- (2015) Yang Xiao et al. Cardiovascular Diabetology
- Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue
- (2015) Murielle M. Véniant et al. Cell Metabolism
- Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
- (2015) Bryn M. Owen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Serum FGF21 levels are associated with brown adipose tissue activity in humans
- (2015) Mark J.W. Hanssen et al. Scientific Reports
- Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1
- (2015) Ricardo J. Samms et al. Cell Reports
- Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex
- (2015) Ganesh Kolumam et al. EBioMedicine
- Fibroblast growth factor 21 protects the heart from oxidative stress
- (2014) Anna Planavila et al. CARDIOVASCULAR RESEARCH
- The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target
- (2014) Wen-Yue Liu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis
- (2014) Manoja K. Brahma et al. JOURNAL OF LIPID RESEARCH
- Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
- (2014) Jae Myoung Suh et al. NATURE
- Monoclonal Antibody Targeting of Fibroblast Growth Factor Receptor 1c Ameliorates Obesity and Glucose Intolerance via Central Mechanisms
- (2014) Christopher J. Lelliott et al. PLoS One
- A nontumorigenic variant of FGF19 treats cholestatic liver diseases
- (2014) J. Luo et al. Science Translational Medicine
- FGF21-based pharmacotherapy – potential utility for metabolic disorders
- (2014) Ruth E. Gimeno et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Inventing new medicines: The FGF21 story
- (2014) Alexei Kharitonenkov et al. Molecular Metabolism
- Differential Enzyme-Linked Immunosorbent Assay and Ligand-Binding Mass Spectrometry for Analysis of Biotransformation of Protein Therapeutics: Application to Various FGF21 Modalities
- (2013) Todd Hager et al. ANALYTICAL CHEMISTRY
- Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors
- (2013) Wing Sun Chow et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Polyethylene Glycol Modified FGF21 Engineered to Maximize Potency and Minimize Vacuole Formation
- (2013) Jing Xu et al. BIOCONJUGATE CHEMISTRY
- A Novel Approach to Improve the Function of FGF21
- (2013) Richard Smith et al. BIODRUGS
- Fibroblast growth factor receptors, developmental corruption and malignant disease
- (2013) F. C. Kelleher et al. CARCINOGENESIS
- Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
- (2013) Yun Shen et al. Cardiovascular Diabetology
- Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
- (2013) Zhuofeng Lin et al. Cell Metabolism
- An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
- (2013) William L. Holland et al. Cell Metabolism
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction
- (2013) Janka Hindricks et al. CLINICAL ENDOCRINOLOGY
- High Glucose Represses -Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets: Involvement of Peroxisome Proliferator-Activated Receptor Signaling
- (2013) W. Y. So et al. DIABETES
- Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
- (2013) Jun Zhang et al. DRUG DISCOVERY TODAY
- Fibroblast Growth Factor 21 Improves Insulin Resistance and Ameliorates Renal Injury indb/dbMice
- (2013) H. W. Kim et al. ENDOCRINOLOGY
- Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice
- (2013) Raul C. Camacho et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- FGF21 contributes to neuroendocrine control of female reproduction
- (2013) Bryn M Owen et al. NATURE MEDICINE
- FGF21 regulates metabolism and circadian behavior by acting on the nervous system
- (2013) Angie L Bookout et al. NATURE MEDICINE
- Antibody-Mediated Activation of FGFR1 Induces FGF23 Production and Hypophosphatemia
- (2013) Ai-Luen Wu et al. PLoS One
- LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
- (2013) Andrew C. Adams et al. PLoS One
- FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/β-Klotho Bispecific Protein
- (2013) Richard Smith et al. PLoS One
- Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
- (2013) A. Planavila et al. Nature Communications
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
- (2012) Paul A. Dutchak et al. CELL
- Circulating Fibroblast Growth Factors as Metabolic Regulators—A Critical Appraisal
- (2012) Bo Angelin et al. Cell Metabolism
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
- (2012) Xunshan Ding et al. Cell Metabolism
- Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques
- (2012) So-Yeon An et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys
- (2012) Murielle M. Véniant et al. ENDOCRINOLOGY
- Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
- (2012) M. J. Potthoff et al. GENES & DEVELOPMENT
- FGF21 regulates PGC-1 and browning of white adipose tissues in adaptive thermogenesis
- (2012) f. M. Fisher et al. GENES & DEVELOPMENT
- Fibroblast Growth Factor 21 (FGF21) Inhibits Chondrocyte Function and Growth Hormone Action Directly at the Growth Plate
- (2012) Shufang Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Conversion of a Paracrine Fibroblast Growth Factor into an Endocrine Fibroblast Growth Factor
- (2012) Regina Goetz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mild Cold Exposure Modulates Fibroblast Growth Factor 21 (FGF21) Diurnal Rhythm in Humans: Relationship between FGF21 Levels, Lipolysis, and Cold-Induced Thermogenesis
- (2012) Paul Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Unique FGF23 with the Ability to Activate FGFR Signaling through Both αKlotho and βKlotho
- (2012) Xinle Wu et al. JOURNAL OF MOLECULAR BIOLOGY
- Klotho Coreceptors Inhibit Signaling by Paracrine Fibroblast Growth Factor 8 Subfamily Ligands
- (2012) R. Goetz et al. MOLECULAR AND CELLULAR BIOLOGY
- A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
- (2012) Johan W. Jonker et al. NATURE
- Characterization of a FGF19 Variant with Altered Receptor Specificity Revealed a Central Role for FGFR1c in the Regulation of Glucose Metabolism
- (2012) Hongfei Ge et al. PLoS One
- Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
- (2012) Dorothy M. French et al. PLoS One
- FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
- (2012) Murielle M. Véniant et al. PLoS One
- Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes
- (2012) Randy Hecht et al. PLoS One
- Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor
- (2012) W. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the Klotho/FGFR1c Receptor Complex
- (2012) I. N. Foltz et al. Science Translational Medicine
- The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
- (2012) Yuan Zhang et al. eLife
- The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue
- (2012) Andrew C. Adams et al. Molecular Metabolism
- Hormone-like fibroblast growth factors and metabolic regulation
- (2011) Yun Chau Long et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents
- (2011) J. Mu et al. DIABETES
- Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21)in Vivo
- (2011) ffolliott M. Fisher et al. ENDOCRINOLOGY
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
- (2011) Elayne Hondares et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes
- (2011) Yang Xiao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association between serum fibroblast growth factor 21 and diabetic nephropathy
- (2011) Wei-Xia Jian et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Unknown
- (2011) Dionysios Chartoumpekis et al. MOLECULAR MEDICINE
- FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways
- (2011) Ai-Luen Wu et al. PLoS One
- A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
- (2011) Zhifeng Huang et al. PLoS One
- Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese
- (2011) Zhuofeng Lin et al. PLoS One
- Amelioration of Type 2 Diabetes by Antibody-Mediated Activation of Fibroblast Growth Factor Receptor 1
- (2011) A.-L. Wu et al. Science Translational Medicine
- Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease
- (2010) Nobuyuki Itoh CELL AND TISSUE RESEARCH
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile
- (2010) Zhuofeng Lin et al. PLoS One
- Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)
- (2010) X. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FGF21 reloaded: challenges of a rapidly growing field
- (2010) Alexei Kharitonenkov et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Fibroblast growth factor 21: from pharmacology to physiology
- (2009) Steven A Kliewer et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects
- (2009) Jing Xu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
- (2009) A. O. Chavez et al. DIABETES CARE
- Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity
- (2009) Eric D. Berglund et al. ENDOCRINOLOGY
- Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis
- (2009) Michael K. Badman et al. ENDOCRINOLOGY
- Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 inob/obmice
- (2009) Xiaofan Li et al. FEBS LETTERS
- FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
- (2009) Xinle Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Different roles of N- and C- termini in the functional activity of FGF21
- (2009) Radmila Micanovic et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects
- (2009) Huating Li et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
- (2008) Takeshi Inagaki et al. Cell Metabolism
- Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
- (2008) M. Mraz et al. CLINICAL ENDOCRINOLOGY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity
- (2008) Peter Arner et al. FEBS LETTERS
- FGF21 N- and C-termini play different roles in receptor interaction and activation
- (2008) Junming Yie et al. FEBS LETTERS
- C-terminal Tail of FGF19 Determines Its Specificity toward Klotho Co-receptors
- (2008) Xinle Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- βKlotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c
- (2008) Masashi Suzuki et al. MOLECULAR ENDOCRINOLOGY
- FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
- (2007) Alexei Kharitonenkov et al. JOURNAL OF CELLULAR PHYSIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started